- Home
- SSTI vs MCRB Comparison
SSTI vs MCRB Comparison
Compare SSTI & MCRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSTI
- MCRB
- Stock Information
- Founded
- SSTI 1996
- MCRB 2010
- Country
- SSTI United States
- MCRB United States
- Employees
- SSTI N/A
- MCRB N/A
- Industry
- SSTI Computer Software: Prepackaged Software
- MCRB Biotechnology: Pharmaceutical Preparations
- Sector
- SSTI Technology
- MCRB Health Care
- Exchange
- SSTI Nasdaq
- MCRB Nasdaq
- Market Cap
- SSTI 161.5M
- MCRB 131.0M
- IPO Year
- SSTI 2017
- MCRB 2015
- Fundamental
- Price
- SSTI $13.11
- MCRB $0.73
- Analyst Decision
- SSTI Buy
- MCRB Buy
- Analyst Count
- SSTI 7
- MCRB 4
- Target Price
- SSTI $21.83
- MCRB $5.63
- AVG Volume (30 Days)
- SSTI 49.0K
- MCRB 2.0M
- Earning Date
- SSTI 02-25-2025
- MCRB 03-04-2025
- Dividend Yield
- SSTI N/A
- MCRB N/A
- EPS Growth
- SSTI N/A
- MCRB N/A
- EPS
- SSTI N/A
- MCRB N/A
- Revenue
- SSTI $104,665,000.00
- MCRB $126,325,000.00
- Revenue This Year
- SSTI $15.88
- MCRB N/A
- Revenue Next Year
- SSTI $2.47
- MCRB N/A
- P/E Ratio
- SSTI N/A
- MCRB N/A
- Revenue Growth
- SSTI 19.39
- MCRB 12856.41
- 52 Week Low
- SSTI $9.33
- MCRB $0.54
- 52 Week High
- SSTI $22.57
- MCRB $1.53
- Technical
- Relative Strength Index (RSI)
- SSTI 55.03
- MCRB 37.88
- Support Level
- SSTI $12.24
- MCRB $0.71
- Resistance Level
- SSTI $14.02
- MCRB $0.91
- Average True Range (ATR)
- SSTI 0.55
- MCRB 0.06
- MACD
- SSTI -0.00
- MCRB -0.02
- Stochastic Oscillator
- SSTI 48.88
- MCRB 8.37
About SSTI SoundThinking Inc.
SoundThinking Inc is a public safety technology company that combines transformative solutions and strategic advisory services for law enforcement and civic leadership. Its flagship SafetySmart platform includes ShotSpotter, the acoustic gunshot detection system, CrimeTracer, the foremost law enforcement search engine, CaseBuilder, a one-stop investigation management system, and ResourceRouter, software that directs patrol and community anti-violence resources to help maximize their impact.
About MCRB Seres Therapeutics Inc.
Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.